L-AP4 monohydrate  

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 10mg in glass bottle
产品描述:基本信息 产品编号: L11025 产品名称: L-AP4 monohydrate CAS: 2247534-79-6   储存条件 粉末 -20℃ 四年 分子式: C4H12NO6P 溶于液体 -80℃(密封储存) 6个月 分子量: 201.11 -20℃(密封储存) 1个月 化学名:    Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 一种有效的、代谢型谷氨酸受体 (mGluR) 的特异性激动剂。 靶点 mGlu4 0.13μM (EC50) mGlu8 0.29μM (EC50) mGlu6 1.0μM (EC50) mGlu7 249μM (EC50) 体内研究 L-AP4 (5-30μg,intrathecal inhection 4-5 days) significantly increases the paw withdrawal threshold in response to application of von Frey filaments in eight nerve-ligated rats in a dose-dependent manner.Intrathecal administration of different doses of L-AP4 is not associated with any evident motor dysfunction.Intrathecal injection of 30μg of L-AP4 does not significantly alter the paw withdrawal latency in these normal rats.Topical application of 5 to 50μM L-AP4 to the spinal cord significantly inhibited the evoked response of neurons to touch,pressure,pinch,and von Frey filaments in a concentration-dependent fashion. Animal Model: Rats. Dosage: 5-30μg. Administration: Intrathecal inhection 4-5 days. Result: Dose-dependently increased paw withdrawal threshold.
保存条件:-20℃